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Abstract 
HIPK2, a cell fate decision kinase inactivated in several human cancers, is thought to exert its oncosuppressing activity 
through its p53-dependent and -independent apoptotic function. However, a HIPK2 role in cell proliferation has also 
been described. In particular, HIPK2 is required to complete cytokinesis and impaired HIPK2 expression results in 
cytokinesis failure and tetraploidization. Since tetraploidy may yield to aneuploidy and chromosomal instability (CIN), 
we asked whether unscheduled tetraploidy caused by loss of HIPK2 might contribute to tumorigenicity. Here, we show 
that, compared to Hipk2+/+ mouse embryo fibroblasts (MEFs), hipk2-null MEFs accumulate subtetraploid karyotypes 
and develop CIN. Accumulation of these defects inhibits proliferation and spontaneous immortalization of primary 
MEFs whereas increases tumorigenicity when MEFs are transformed by E1A and Harvey-Ras oncogenes. Upon mouse 
injection, E1A/Ras-transformed hipk2-null MEFs generate tumors with genetic alterations resembling those of human 
cancers derived by initial tetraploidization events, such as pancreatic adenocarcinoma. Thus, we evaluated HIPK2 
expression in different stages of pancreatic transformation. Importantly, we found a significant correlation among 
reduced HIPK2 expression, high grade of malignancy, and high nuclear size, a marker of increased ploidy. Overall, 
these results indicate that HIPK2 acts as a caretaker gene, whose inactivation increases tumorigenicity and causes CIN 
by cytokinesis failure.  
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